{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:21:15Z","timestamp":1791570075564,"version":"4.3.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109367","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T17:47:23Z","timestamp":1414432043000},"page":"e109367","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Sanne","family":"Terryn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Francart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lamoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hultberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Rommelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wittelsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Meerschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Ottevaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catelijne","family":"Stortelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vanlandschoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Gucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/17460794.3.5.481","article-title":"Concepts in the pathogenesis of rabies","volume":"3","author":"B Dietzschold","year":"2008","journal-title":"Future Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","author":"T Hemachudha","year":"2002","journal-title":"The Lancet Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5","article-title":"Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures","volume":"23","author":"P Lewis","year":"2000","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.coph.2008.07.006","article-title":"Single-domain antibodies as building blocks for novel therapeutics","volume":"8","author":"D Saerens","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"MM Harmsen","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","article-title":"Single domain antibodies: promising experimental and therapeutic tools in infection and immunity","volume":"198","author":"J Wesolowski","year":"2009","journal-title":"Medical Microbiology and Immunology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"A Hultberg","year":"2011","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.vaccine.2009.01.110","article-title":"Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs","volume":"27","author":"MM Harmsen","year":"2009","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","article-title":"Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection","volume":"203","author":"LI Iba\u00f1ez","year":"2011","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jir622","article-title":"Nanobodies(R) specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion","volume":"204","author":"B Schepens","year":"2011","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1003334","DOI":"10.1371\/journal.ppat.1003334","article-title":"Recombinant Monovalent Llama-Derived Antibody Fragments (VHH) to Rotavirus VP6 Protect Neonatal Gnotobiotic Piglets against Human Rotavirus-Induced Diarrhea","volume":"9","author":"CG Vega","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies","volume":"84","author":"CL Schumacher","year":"1989","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","article-title":"The incurable wound revisited: progress in human rabies prevention?","volume":"19","author":"CA Hanlon","year":"2001","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a Cocktail of Recombinant-Expressed Human Rabies Virus-Neutralizing Monoclonal Antibodies for Postexposure Prophylaxis of Rabies","volume":"188","author":"M Prosniak","year":"2003","journal-title":"Journal of Infectious Diseases"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coi.2008.06.005","article-title":"Antibodies against viruses: passive and active immunization","volume":"20","author":"M Law","year":"2008","journal-title":"Current Opinion in Immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-7-43","article-title":"Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab\u2032)2 in mice","volume":"7","author":"J Lu","year":"2006","journal-title":"Respiratory Research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"AJ Hessell","year":"2007","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"L Both","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1128\/JVI.02368-06","article-title":"The Rabies Virus Glycoprotein Receptor p75NTR Is Not Essential for Rabies Virus Infection","volume":"81","author":"C Tuffereau","year":"2007","journal-title":"Journal of Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1073\/pnas.89.15.7252","article-title":"Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system","volume":"89","author":"B Dietzschold","year":"1992","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e71383","DOI":"10.1371\/journal.pone.0071383","article-title":"Single Domain Antibody Multimers Confer Protection against Rabies Infection","volume":"8","author":"BM Boruah","year":"2013","journal-title":"PLoS ONE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0042-6822(91)90145-2","article-title":"Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation","volume":"183","author":"F Lafay","year":"1991","journal-title":"Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"S J\u00e4hnichen","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26145","article-title":"A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth","volume":"129","author":"RC Roovers","year":"2011","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(93)91606-S","article-title":"The CVS strain of rabies virus as transneuronal tracer in the olfactory system of mice","volume":"619","author":"L Astic","year":"1993","journal-title":"Brain Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4155\/bio.13.78","article-title":"Key bioanalytical measurements for antibody-drug conjugate development: PK\/PD modelers&apos; perspective","volume":"5","author":"DK Shah","year":"2013","journal-title":"Bioanalysis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.111.183483","article-title":"Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration","volume":"339","author":"RB Pepinsky","year":"2011","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1096\/fj.11-201384","article-title":"Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging","volume":"26","author":"T Li","year":"2012","journal-title":"The FASEB Journal"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and Design of Peptides as a New Drug Delivery System for the Brain","volume":"324","author":"M Demeule","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref30","article-title":"Evaluation of prophylactic efficacy of human anti-rabier monoclonal antibodies in a mouse model [dissertation]","year":"2005"},{"key":"ref31","first-page":"425","article-title":"Rabies vaccines WHO position paper","volume":"49\/50","year":"2007"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0001-706X(98)00038-2","article-title":"Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in ssociation with a purified, Vero-cell rabies vaccine","volume":"70","author":"J Lang","year":"1998","journal-title":"Acta Tropica"},{"key":"ref33","article-title":"Pharmacokinetic-Pharmacodynamic modeling of ALX-0061, a novel humanized Nanobody Il-6R inhibitor for rheumatoid arthritis","volume":"1","author":"R Rossenu","year":"2012","journal-title":"Clin Pharmacol Drug Develop"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1016\/j.vaccine.2005.05.017","article-title":"Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins","volume":"23","author":"MM Harmsen","year":"2005","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2011.01.019","article-title":"A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus","volume":"173","author":"V Rosseels","year":"2011","journal-title":"J Virol Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"256175","DOI":"10.1155\/2014\/256175","article-title":"A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test","volume":"2014","author":"V Suin","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref37","first-page":"e3564","article-title":"Whole Animal Perfusion Fixation for Rodents","author":"GJ Gage","year":"2012"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological Parameter Values for Physiologically Based Pharmacokinetic Models","volume":"13","author":"RP Brown","year":"1997","journal-title":"Toxicology and Industrial Health"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:25:20Z","timestamp":1588994720000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109367"}},"subtitle":[],"editor":[{"given":"Matthias Johannes","family":"Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,27]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109367","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,27]]}}}